NOVAVAX INC — Director's Dealing 2021

Jun 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2021-06-17

Reporting Person: Alton Gregg H (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-17	Stock Option (Right to Buy)	$179.89	A	1300	Acquired	2031-06-17	Common Stock (1300)	Direct
2021-06-17	Restricted Stock Units	$	A	700	Acquired		Common Stock (700)	Direct

Footnotes

F1: One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan") will vest one (1) year from the June 17, 2021 grant date (the "Grant Date") subject to continued service on the Company's Board of Directors through the vesting date.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.

F3: One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date.